Switch to:
Cascadian Therapeutics Inc (NAS:CASC)
Additional Paid-In Capital
$296.53 Mil (As of Jun. 2016)

Cascadian Therapeutics Inc's quarterly additional paid-in capital increased from Dec. 2015 ($249.57 Mil) to Mar. 2016 ($252.47 Mil) and increased from Mar. 2016 ($252.47 Mil) to Jun. 2016 ($296.53 Mil).

Cascadian Therapeutics Inc's annual additional paid-in capital increased from Dec. 2013 ($154.83 Mil) to Dec. 2014 ($224.55 Mil) and increased from Dec. 2014 ($224.55 Mil) to Dec. 2015 ($249.57 Mil).


Definition

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)*Shares Outstanding

Related Terms

Shares Outstanding


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Cascadian Therapeutics Inc Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
AdditionalPaidInCapital 11.9513.6415.0916.2917.3374.54126.83154.83224.55249.57

Cascadian Therapeutics Inc Quarterly Data

Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16Jun16
AdditionalPaidInCapital 155.58156.18224.06224.55247.47248.20248.74249.57252.47296.53
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK